海普瑞（002399）发布2025年度利润分配预案，拟高比例现金分红
主要亮点
- 2025年度利润分配方案：公司拟以2025年末总股本1,467,296,204股为基数，每10股派发现金红利1.45元（含税），共计派发现金红利212,757,949.58元。
- 现金分红比例：本年度现金分红总额占归属于上市公司股东净利润的60.88%，显示公司重视股东回报。
- 未分配利润：2025年母公司报表可供分配利润为214,046,629.84元，剩余利润作为未分配利润留存。
- 不送红股、不转增资本：本次利润分配不涉及送红股或资本公积金转增股本。
- 审议流程：该预案已由董事会全票通过，尚需提交股东大会审议。
- 公司业绩：2025年度合并报表归属于上市公司股东净利润为349,485,811.78元，母公司报表净利润为-203,049,684.51元。
- 三年分红数据：最近三年累计现金分红579,582,000.58元，远超三年平均净利润的30%，符合监管要求。
- 风险提示：公司不触及《深圳证券交易所股票上市规则》第9.8.1条第（九）项规定的风险警示情形。
- 股本变动应对：若因股权激励、可转债转股、股份回购等导致股本变动，将保持分红总额不变，调整每股分配比例。
- 财务安全性：公司2024、2025年度金融资产占总资产比例分别为15.36%、20.02%，低于50%，未出现异常风险。
对股东和股价的影响
- 高比例现金分红：公司持续高比例现金分红，绝对金额和净利润比例均较高，显示公司盈利稳定且重视投资者回报，有望提升市场信心和估值。
- 未分配利润充足：公司仍有较多未分配利润，为未来分红、投资和发展提供资金保障。
- 经营状况：公司2025年度母公司净利润为负，但整体合并利润为正，需关注母公司亏损原因及后续影响。
- 未触及风险警示：未触及分红不足等风险警示，有利于股价稳定。
- 若股本变动：分红总额保持不变，有助于分红政策的持续性和透明度。
- 财务稳健：金融资产比例合理，未出现资产配置风险。
投资者须知
- 该分红预案尚需股东大会审议通过。
- 公司2025年度未实施股份回购。
- 分红方案合理且合规，符合监管指引和公司章程。
- 如有股本变动，分红总额不变，仅调整每股分配比例。
总结
海普瑞2025年度利润分配预案展现出公司持续稳定的盈利能力和强烈的股东回报意愿。高比例现金分红、充足未分配利润及合理的财务结构，对投资者而言具有积极信号，可能提振股价。唯一需关注的是母公司报表亏损的具体原因及后续影响，整体来看公司基本面稳健，分红政策优良。
免责声明：本文仅为信息披露解读，不构成投资建议。投资者需结合自身风险偏好和市场变化，谨慎决策。
Hepalink (002399) Announces 2025 Dividend Plan: High Cash Dividend Ratio and Strong Shareholder Returns
Key Highlights
- 2025 Dividend Proposal: The company plans to pay a cash dividend of RMB 1.45 (tax-inclusive) per 10 shares based on the total share capital of 1,467,296,204 shares at the end of 2025, totaling RMB 212,757,949.58.
- Cash Dividend Ratio: The cash dividend is 60.88% of the net profit attributable to shareholders, indicating a strong commitment to shareholder returns.
- Undistributed Profits: The parent company’s distributable profit is RMB 214,046,629.84; remaining profits will be retained.
- No Bonus Shares/Capitalization: No bonus shares or capital reserve capitalization in this plan.
- Approval Process: The plan has board approval and awaits shareholder meeting approval.
- Performance: 2025 consolidated net profit attributable to shareholders: RMB 349,485,811.78; parent company net profit: RMB -203,049,684.51 (loss).
- Three-Year Dividend Data: Last three years’ cumulative cash dividends: RMB 579,582,000.58, far exceeding the average net profit threshold (30%), meeting regulatory requirements.
- Risk Alert: The company does not trigger the Shenzhen Stock Exchange risk warning rules.
- Share Capital Changes: If share capital changes (ESOP, convertibles, buybacks), total dividend remains unchanged, per-share ratio will be adjusted.
- Financial Safety: Financial assets accounted for 15.36% (2024) and 20.02% (2025) of total assets, well below the 50% risk threshold.
Impact on Shareholders and Share Price
- High Dividend Ratio: Consistent high cash dividend ratio highlights stable profitability and strong investor returns, likely to boost market confidence and valuation.
- Ample Undistributed Profits: Undistributed profits provide future dividend and investment flexibility.
- Parent Company Loss: The parent company posted a loss; investors should monitor the cause and future implications.
- No Risk Warning: No regulatory risk warning, supporting share price stability.
- Dividend Policy Stability: Dividend total remains unchanged in case of share capital changes, improving policy transparency.
- Financially Sound: Financial asset ratios are reasonable, no asset risk detected.
Investor Notes
- Dividend plan requires shareholder approval.
- No share buybacks in 2025.
- The plan is reasonable, compliant with regulatory guidance and company charter.
- Dividend total remains unchanged for share capital changes; per-share ratio will be adjusted.
Summary
Hepalink’s 2025 dividend plan demonstrates sustainable profitability and a strong commitment to shareholder returns. High cash dividend ratio, ample undistributed profits, and sound financial structure send positive signals to investors and may boost share price. The only concern is the parent company’s loss; investors should monitor this. Overall, the company’s fundamentals are solid and its dividend policy is attractive.
Disclaimer: This article is for information disclosure interpretation only and does not constitute investment advice. Investors should make cautious decisions based on their risk preferences and market conditions.
View 海普瑞 Historical chart here
